Glenmark Pharma shares soar 8% on FDA clean report, Investec predicts 17% upside

September 23, 2024

The global brokerage firm said that it expects both earnings momentum and importantly cash flow generation to continue. Additionally, it sees Glenmark as more of an India / RoW play as these two contribute >70% of its EBITDA.

More To Explore

Delhivery shares surge 2% as CCI approves Rs 1,407-crore Ecom Express deal

The Competition Commission of India has approved Delhivery’s acquisition of Ecom Express. This deal is worth approximately Rs 1,407 crore. It will significantly consolidate India’s

June 18, 2025

UGRO Capital shares rally 7% as firm to acquire Profectus Capital for Rs 1,400 crore cash deal

UGRO Capital’s shares surged following the announcement of its acquisition of Profectus Capital for Rs 1400 crore. This all-cash deal is expected to boost UGRO’s

June 18, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003